Real-World Data Reflect Shorter Survival With Pembrolizumab in Older NSCLC Population – OncLive
CONTEXT: Report of a retrospective cohort study publish in JAMA Network Open describing the use of Keytruda (Pembrolizumab) alone and in combination with chemotherapy in the treatment of NSCLC | Continue Reading